Cytokinetics | CYTK - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Arca Biopharma USD 31.78M 8.81M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Biogen USD 3.9B 18.7M 2026-09
Brainstorm Cell Therapeutics USD 12.38M 621K 2026-06
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Capricor Therapeutics USD 29.9M 3.07M 2026-09
Cytokinetics USD 353.42M 171.99M 2026-09
Eisai JPY 371.5B 22.14B 2026-09
Eli Lilly USD 47B 745M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Geron USD 74.25M 3.92M 2026-09
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
Merck USD 28.8B 1.07B 2026-09
Novartis USD 32.52B 777M 2026-09
Pfizer USD 31.73B 920M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09